Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9533
+0.0748 (8.51%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Estrella Immunopharma Statistics

Total Valuation

ESLA has a market cap or net worth of $34.48 million. The enterprise value is $30.86 million.

Market Cap 34.48M
Enterprise Value 30.86M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

ESLA has 36.17 million shares outstanding. The number of shares has increased by 255.55% in one year.

Current Share Class 36.17M
Shares Outstanding 36.17M
Shares Change (YoY) +255.55%
Shares Change (QoQ) -0.87%
Owned by Insiders (%) 2.70%
Owned by Institutions (%) 0.81%
Float 9.91M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 221.23
P/TBV Ratio 221.05
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.55, with a Debt / Equity ratio of 0.03.

Current Ratio 0.55
Quick Ratio 0.31
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -6,160.07%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ESLA has paid $126 in taxes.

Income Tax 126
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -10.49% in the last 52 weeks. The beta is 0.44, so ESLA's price volatility has been lower than the market average.

Beta (5Y) 0.44
52-Week Price Change -10.49%
50-Day Moving Average 1.01
200-Day Moving Average 1.11
Relative Strength Index (RSI) 58.11
Average Volume (20 Days) 92,472

Short Selling Information

The latest short interest is 17,024, so 0.05% of the outstanding shares have been sold short.

Short Interest 17,024
Short Previous Month 22,554
Short % of Shares Out 0.05%
Short % of Float 0.17%
Short Ratio (days to cover) 0.41

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -8.85M
Pretax Income -6.09M
Net Income -8.85M
EBITDA n/a
EBIT -8.85M
Earnings Per Share (EPS) -$0.24
Full Income Statement

Balance Sheet

The company has $916,916 in cash and $4,000 in debt, giving a net cash position of $912,916 or $0.03 per share.

Cash & Cash Equivalents 916,916
Total Debt 4,000
Net Cash 912,916
Net Cash Per Share $0.03
Equity (Book Value) 143,731
Book Value Per Share 0.00
Working Capital -1.36M
Full Balance Sheet

Cash Flow

Operating Cash Flow -6.23M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ESLA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -255.55%
Shareholder Yield -255.55%
Earnings Yield -27.87%
FCF Yield n/a

Analyst Forecast

The average price target for ESLA is $16.00, which is 1,578.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target $16.00
Price Target Difference 1,578.38%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1